Onconic Therapeutics Inc
KOSDAQ:476060
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Onconic Therapeutics Inc
KOSDAQ:476060
|
KR |
|
R
|
Renegade Gold Inc
F:070
|
CA |
|
S
|
Samsung Special Purpose Acquisition 8 Co
KOSDAQ:448740
|
KR |
|
T
|
Tokyo Koatsu Co Ltd
TSE:7139
|
JP |
|
O
|
Orphazyme A/S
F:1TB
|
DK |
|
Premier Capital Services Ltd
BSE:511016
|
IN |
|
S
|
S & P Syndicate PCL
SET:SNP
|
TH |
|
T
|
Twenty Four Con and Supply PCL
SET:24CS
|
TH |
|
ITL Industries Ltd
BSE:522183
|
IN |
|
A
|
Appian Corp
F:910
|
US |
|
H
|
Hana 33 Special Purpose Acquisition Co
KOSDAQ:475250
|
KR |
|
Imperial Helium Corp
XTSX:IHC
|
CA |
|
Libero Copper & Gold Corp
XTSX:LBC
|
CA |
|
Trek Metals Ltd
ASX:TKM
|
BM |
|
Tsentral'nyi Telegraf PAO
MOEX:CNTL
|
RU |
|
N
|
NH Special Purpose Acquisition 22 Co
KOSDAQ:396770
|
KR |
|
M
|
MSTNS Co Ltd
KOSDAQ:257370
|
KR |
|
N
|
NeutriSci International Inc
F:1N9
|
CA |
|
S
|
Shenglong Splendecor International Ltd
HKEX:8481
|
CN |
|
M
|
Market Connections Asia PCL
SET:MCA
|
TH |
|
L
|
LY Corporation Ltd
SGX:1H8
|
MY |
|
Spirit Airlines Inc
NYSE:SAVE
|
US |
|
J
|
JMC Electronics Co Ltd
TWSE:6552
|
TW |
|
A
|
Agrometal Soc Anon Ind
BCBA:AGRO
|
AR |
Shareholder Yield
Current shareholder yield for Onconic Therapeutics Inc is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Onconic Therapeutics Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -34% |
| Market Capitalization | 664.8B KRW |
| Shares Outstanding | 45 410 000 |
| Percentage of Shares Shorted |
N/A
|
